Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients

Serological diagnosis of avian influenza in poultry: is the haemagglutination inhibition test really the ‘gold standard’?

(2012) Arianna Comin et al.   Influenza and Other Respiratory Viruses

Development of an enzyme-linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion

(2012) Jesse Bodle et al.   Influenza and Other Respiratory Viruses

A BAFF/APRIL-dependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce AID expression and Ig class-switching in B cells

(2011) M. Bombardieri et al.   ANNALS OF THE RHEUMATIC DISEASES

B lymphocyte stimulator levels in systemic lupus erythematosus: Higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels

(2011) Lauren L. Ritterhouse et al.   ARTHRITIS AND RHEUMATISM

Effect of rituximab on human in vivo antibody immune responses

(2011) Mark D. Pescovitz et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

TNF-α Antagonist Use and Risk of Hospitalization for Infection in a National Cohort of Veterans With Rheumatoid Arthritis

(2011) Michael A. Lane et al.   MEDICINE

The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab

(2011) U. Arad et al.   VACCINE

Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: A systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases

(2010) S. van Assen et al.   AUTOIMMUNITY REVIEWS

Utility of Pandemic H1N1 2009 Influenza Virus Recombinant Hemagglutinin Protein-Based Enzyme-Linked Immunosorbent Assay for Serosurveillance

(2010) V. A. Arankalle et al.   Clinical and Vaccine Immunology

The immortality of humoral immunity

(2010) Raul Elgueta et al.   IMMUNOLOGICAL REVIEWS

Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly

(2010) J. B. Galloway et al.   RHEUMATOLOGY

Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment

(2010) Maria Rehnberg et al.   ARTHRITIS RESEARCH & THERAPY

Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab

(2009) Sander van Assen et al.   ARTHRITIS AND RHEUMATISM

Initiation of rheumatoid arthritis treatments and the risk of serious infections

(2009) Carlos G. Grijalva et al.   RHEUMATOLOGY

The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis

(2009) Daniel E. Furst   SEMINARS IN ARTHRITIS AND RHEUMATISM

BAFF enhances B-cell-mediated immune response and vaccine-protection against a very virulent IBDV in chickens

(2009) Long Chen et al.   VACCINE